S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
OTCMKTS:NMXS

Net Medical Xpress Solutions - NMXS Stock Forecast, Price & News

$0.60
0.00 (0.00%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.60
$0.60
50-Day Range
$0.50
$0.74
52-Week Range
$0.04
$0.75
Volume
N/A
Average Volume
7,236 shs
Market Capitalization
$22.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NMXS stock logo

About Net Medical Xpress Solutions (OTCMKTS:NMXS) Stock

Net Medical Xpress Solutions, Inc. provides telemedicine solutions for hospitals, nursing homes, specialty hospitals, and other medical facilities. It provides services in the areas, such as teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare, and telenephrology. The company offers a Telemed telemedicine platform, a system used to build a customized telemedicine management system for clients; digital paper, development engine, single pane of glass software, FDA cleared image viewers, and integration connectivity with approximately 43 hospitals based EMR systems; and telemedicine video conferencing equipment and USB clinical tools. It also provides physicians; administrative services, such as credentialing, program management, and call center management; and integration services, including electronic prescription software, prior authorization software, laboratory and malpractice insurance, large scale provider scheduling, medical translation, and rounding services. In addition, the company offers staffing and recruiting services, and diagnostic and clinical services, as well as amazon cloud services. The company was formerly known as New Mexico Software, Inc. and changed its name to Net Medical Xpress Solutions, Inc. in January 2013. Net Medical Xpress Solutions, Inc. was founded in 1995 and is based in Albuquerque, New Mexico.

Receive NMXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Net Medical Xpress Solutions and its competitors with MarketBeat's FREE daily newsletter.

NMXS Stock News Headlines

Net Medical Xpress Solutions reports Q2 results
See More Headlines
Receive NMXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Net Medical Xpress Solutions and its competitors with MarketBeat's FREE daily newsletter.

NMXS Company Calendar

Today
8/17/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
OTCMKTS:NMXS
Employees
23
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$22.60 million
Optionable
Not Optionable
Beta
-0.87

Key Executives

  • Mr. Richard F. Govatski (Age 77)
    Chairman & CEO
  • Ms. Teresa B. Dickey (Age 78)
    Treasurer, Sec. & Director
    Comp: $35k
  • Mr. Rafael Rubio
    Pres
  • Ms. Yadira Ortiz
    Chief Financial Officer
  • Mr. Miguel Williams
    Director of Operations & Technical Support













NMXS Stock - Frequently Asked Questions

How have NMXS shares performed in 2022?

Net Medical Xpress Solutions' stock was trading at $0.0789 on January 1st, 2022. Since then, NMXS shares have increased by 660.5% and is now trading at $0.60.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Net Medical Xpress Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Net Medical Xpress Solutions investors own include HEXO (HEXO), BTCS (BTCS), Bunker Hill Mining (BHLL), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY), Aeolus Pharmaceuticals (AOLS), Akari Therapeutics (AKTX), Adicet Bio (ACET) and Aurora Cannabis (ACB).

What is Net Medical Xpress Solutions' stock symbol?

Net Medical Xpress Solutions trades on the OTCMKTS under the ticker symbol "NMXS."

How do I buy shares of Net Medical Xpress Solutions?

Shares of NMXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Net Medical Xpress Solutions' stock price today?

One share of NMXS stock can currently be purchased for approximately $0.60.

How much money does Net Medical Xpress Solutions make?

Net Medical Xpress Solutions (OTCMKTS:NMXS) has a market capitalization of $22.60 million.

How can I contact Net Medical Xpress Solutions?

Net Medical Xpress Solutions' mailing address is 5021 INDIAN SCHOOL ROAD NE SUITE 100, ALBUQUERQUE NM, 87110. The official website for the company is www.nmxs.com. The company can be reached via phone at (505) 255-1999 or via fax at 505-255-7201.

This page (OTCMKTS:NMXS) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.